Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D008875:Middle Aged; D008981:Molsidomine; D009025:Morpholines / Q000494:pharmacology / Q000627:therapeutic use*; D009200:Myocardial Contraction / Q000187:drug effects; D010069:Oxadiazoles / Q000627:therapeutic use*; D005082:Physical Exertion / Q000187:drug effects*; D011877:Radionuclide Imaging; D012146:Rest; D013318:Stroke Volume / Q000187:drug effects; D013558:Sydnones / Q000494:pharmacology / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D009025:Morpholines; D010069:Oxadiazoles; D013558:Sydnones; D008981:Molsidomine